Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Nadia Fathallah"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Display
Original Articles
Anorectal benign disease
Radiofrequency for the treatment of pilonidal disease: results of a French prospective pilot study
Nadia Fathallah, Amine Antonin Alam, Maria Skoufou, Marie Lazareth, Lucas Spindler, Manuel Aubert, Eric Safa Far, Elise Pommaret, Amélie Barré, Mathilde Wisniewski, Sinon Kurt, Dior Marone, Vincent de Parades
Ann Coloproctol. 2026;42(2):198-207.   Published online April 23, 2026
DOI: https://doi.org/10.3393/ac.2025.00850.0121
  • 2,821 View
  • 87 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Purpose
Minimally invasive techniques are increasingly applied in the management of pilonidal disease. While laser therapy is well established, radiofrequency (RF) represents a newer alternative with theoretical advantages. However, no prospective data have yet been published on its use. This study aimed to assess the safety, efficacy, and patient satisfaction associated with RF treatment for infected pilonidal sinus.
Methods
We conducted a prospective, single-center pilot study including consecutive patients treated with RF between March and December 2023. The procedure was performed under spinal or general anesthesia in an outpatient setting using a radial RF probe (25 W, 4 MHz) following mechanical debridement. Patients were followed up at 15 days and at 1, 3, and 6 months. The primary endpoint was safety; secondary endpoints included healing rate, predictors of failure, postoperative pain, return to activities, and patient satisfaction.
Results
Forty-four patients were enrolled (median age, 25.5 years; 31 men, 70.5%), of whom 38.6% had undergone previous surgery. The median operative time was 12 minutes. No major complications occurred, and minor early events were reported in 6.8% of cases. Complete healing at 6 months was achieved in 77.3% of patients. Failure and recurrence rates were 13.6% and 9.1%, respectively. A history of prior surgery significantly increased the risk of failure (odds ratio, 0.2; P=0.005). The median peak pain score was 2 out of 10, with a median duration of 2 days. Overall, 33 patients (75.0%) were very satisfied, and 40 (90.9%) stated they would undergo the procedure again or recommend it to others.
Conclusion
RF appears to be a safe, minimally invasive outpatient treatment option for pilonidal disease, demonstrating promising efficacy, minimal postoperative pain, and high patient satisfaction. Trial registration: ClinicalTrials.gov identifier: NCT05855733.
Benign proctology
Proposal for a New Score: Hemorrhoidal Bleeding Score
Nadia Fathallah, Hélène Beaussier, Gilles Chatellier, Jean Meyer, Marc Sapoval, Nadia Moussa, Vincent de Parades
Ann Coloproctol. 2021;37(5):311-317.   Published online September 18, 2020
DOI: https://doi.org/10.3393/ac.2020.08.19
  • 11,001 View
  • 254 Download
  • 10 Web of Science
  • 15 Citations
AbstractAbstract PDF
Purpose
We conducted a prospective study to evaluate a new hemorrhoidal bleeding score (HBS).
Methods
All consecutive patients who had consulted between May 1, 2016 and June 30, 2017 for bleeding hemorrhoidal disease were prospectively assessed at a proctological department. The study was conducted in 2 stages. The first stage assessed the validity of the score on a prospective patient cohort. A second stage assessed the interobserver reproducibility of the score on another prospective cohort.
Results
One hundred consecutive patients were studied (57 males; mean age, 49.70 years). A positive association between HBS and surgery indication was found (P<0.001). A cut-off value of the score of 5 (≤5 vs. >5) separated patients from surgical to medical-instrumental treatment with a sensitivity and specificity of 75.00% and 81.25%, respectively. In the multivariate analysis, only HBS was significantly associated with the operative decision (odds ratio, 12.22). Prolapse was no longer significantly associated with the surgical indication. After a mean follow-up after treatment of 7 months, HBS improved statistically significantly (P<0.0001). For the reproducibility of the score, an additional 30 consecutive patients (13 males; mean age, 53.14 years) were enrolled with an excellent agreement between 2 proctologists (kappa=0.983).
Conclusion
HBS is sensitive, specific, and reproducible. It can assess the severity of hemorrhoidal bleeding. It can discriminate between the most severe surgery-indicated patients and does so in a more efficient way than the Goligher prolapse score. It also allows quantifying the extent of change in hemorrhoidal bleeding after treatment.

Citations

Citations to this article as recorded by  
  • Arterial Embolization for the Internal Hemorrhoids Management: A Systematic Review
    Mohammad Hossein Golezar, Hamed Ghorani, Fakhroddin Alemi, Farzad Fayedeh, Maryam Yeganegi, Samaneh Toutounchian, Hanieh Amani, Hadi Rokni Yazdi
    Health Science Reports.2026;[Epub]     CrossRef
  • Efficacy of escin combined with micronized purified flavonoid fraction in controlling bleeding and preventing recurrence of acute internal hemorrhoids: a randomized controlled trial
    Witcha Vipudhamorn, Pawit Sutharat, Suwan Sanmee, Ekkarin Supatrakul, Sunhawit Junrungsee
    Annals of Coloproctology.2026; 42(3): 273.     CrossRef
  • Hémorroïdes
    A.A. Alam, N. Fathallah, V. de Parades
    EMC - Gastro-entérologie.2026; 43(4): 1.     CrossRef
  • The efficacy of Aescin combined with MPFF for early control of bleeding from acute hemorrhoids, A randomized controlled trial
    Suwan Sanmee, Witcha Vipudhamorn, Pawit Sutharat, Ekkarin Supatrakul
    Asian Journal of Surgery.2025; 48(1): 193.     CrossRef
  • Hemorrhoidal disease: what role can rectal artery embolization play?
    Julien Panneau, Diane Mege, Mathieu Di Bisceglie, Julie Duclos, Idir Khati, Vincent Vidal, Gaetano Gallo, Farouk Tradi
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Artery Embolization in the Treatment of Refractory Internal Hemorrhoids
    Layth Alkhani, Jessica Stewart, Osman Ahmed
    Applied Radiology.2025; 1(1): 1.     CrossRef
  • Hemorrhoidal disease: Epidemiological study and analysis of predictive factors for surgical management
    Nadia Fathallah, Amine Alam, Anne L. Rentien, Giorgio La Greca, Joshua Co, Elise Pommaret, Amélie Barré, Stéphane Kegne, Hélène Beaussier, Lucas Spindler, Vincent de Parades
    Journal of Visceral Surgery.2024; 161(3): 161.     CrossRef
  • Pathologie hémorroïdaire : étude épidémiologique et analyse des facteurs de risque de chirurgie
    Nadia Fathallah, Amine Alam, Anne-Laure Rentien, Giorgio La Greca, Joshua Co, Elise Pommaret, Amélie Barré, Stéphane Kegne, Hélène Beaussier, Lucas Spindler, Vincent de Parades
    Journal de Chirurgie Viscérale.2024; 161(3): 177.     CrossRef
  • Imaging for Hemorrhoidal Disease: Navigating Rectal Artery Embolization from Planning to Follow-up
    Jonathan Lindquist, James Hart, Katherine Marchak, Eduardo Bent Robinson, Premal Trivedi
    Seminars in Interventional Radiology.2024; 41(03): 263.     CrossRef
  • Russian multicenter observational HDQ study on the validation of the questionnaire for hemorrhoidal disease
    Yu. A. Shelygin, Yu. M. Stoyko, Ivan V. Kostarev, E. A. Zagriadskiǐ, A. M. Bogomazov, E. B. Golovko, Yu. V. Khomitskaya, B. B. Kvasnikov, O. Zh. Linnik
    Koloproktologia.2024; 23(4): 101.     CrossRef
  • Emborrhoid technique performed on a patient with portal hypertension and chronic hemorrhoidal bleeding as a salvage therapy
    Filipa Alves e Sousa, Pedro Marinho Lopes, Inês Bolais Mónica, Ana Catarina Carvalho, Pedro Sousa
    CVIR Endovascular.2022;[Epub]     CrossRef
  • Emborrhoid: Rectal Artery Embolization for Hemorrhoid Disease
    Julien Panneau, Diane Mege, Mathieu Di Biseglie, Julie Duclos, Paul Habert, Vincent Vidal, Farouk Tradi
    Seminars in Interventional Radiology.2022; 39(02): 194.     CrossRef
  • Rectal Artery Embolization for Hemorrhoidal Disease: Anatomy, Evaluation, and Treatment Techniques
    Julien Panneau, Diane Mege, Mathieu Di Biseglie, Julie Duclos, Paul Habert, Axel Bartoli, Vincent Vidal, Farouk Tradi
    RadioGraphics.2022; 42(6): 1829.     CrossRef
  • Treatment of Hemorrhoid in Unusual Condition-Pregnancy
    Hyo Seon Ryu
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Hemorrhoid embolization: A review of current evidences
    Reza Talaie, Pooya Torkian, Arash Dooghaie Moghadam, Farouk Tradi, Vincent Vidal, Marc Sapoval, Jafar Golzarian
    Diagnostic and Interventional Imaging.2021;[Epub]     CrossRef
Long-term Outcome of a Fissurectomy: A Prospective Single-Arm Study of 50 Operations out of 349 Initial Patients
Jean-David Zeitoun, Pierre Blanchard, Nadia Fathallah, Paul Benfredj, Nicolas Lemarchand, Vincent de Parades
Ann Coloproctol. 2018;34(2):83-87.   Published online April 30, 2018
DOI: https://doi.org/10.3393/ac.2017.06.12
  • 30,593 View
  • 230 Download
  • 21 Web of Science
  • 23 Citations
AbstractAbstract PDF
Purpose
The surgical standard of care for patients with chronic anal fissure is still disputed. We aimed to assess the natural course of idiopathic anal fissure and the long-term outcome of a fissurectomy as a surgical treatment.
Methods
All consecutive patients referred to a single expert practitioner in a tertiary centre were primarily included. A fissurectomy was proposed in cases of refractory symptoms after 4 to 6 weeks of standard medical management. Only patients with idiopathic and noninfected anal fissures were included in this second subsample to undergo surgery. Conventional postoperative management was prescribed for all patients who had undergone surgery. The main outcome measures were the success rate (defined as a combination of wound healing and relief of pain) and postoperative anal continence.
Results
Three hundred forty-nine patients were primarily recruited. Fifty patients finally underwent surgery for an idiopathic and noninfected fissure. Among them, 47 (94%) were cured at the end of primary follow-up, and 44 of the 47 (93.6%) could be confirmed as being sustainably cured in the longer-term follow-up. The mean time of complete healing was 10.3 weeks (range, 5.7–36.4 weeks). All patients were free of pain at weeks 42. The continence score after surgery was not statistically different from the preoperative score.
Conclusion
A fissurectomy for the treatment of patients with an idiopathic noninfected fissure is associated with rapid pain relief and a high success rate even though complete healing may often be delayed. Moreover, it appears to have no adverse effect on continence.

Citations

Citations to this article as recorded by  
  • Current Treatment of Chronic Anal Fissures in Adults: Recommendations and Actual Surgical Practice
    L. I. Hrytsak, L. S. Bilanskyi, M. V. Aksan
    The Ukrainian Journal of Clinical Surgery.2026; 93(2): 78.     CrossRef
  • Fissurectomy with Full-thickness Skin Graft versus Fissurectomy in Chronic anal Fissure: A Comparative Study
    Radharaman Panda
    Indian Journal of Colo-Rectal Surgery.2026; 9(3): 161.     CrossRef
  • Predictors of delayed healing after anal fissure surgery: association of Helicobacter pylori infection and intestinal parasitic infestations with healing outcomes—an observational study
    Reham Zakaria, Khaled M. Kotb, Yasser A. Orban, Mohamed Mahmoud Amin, Heba Alhussein Abo-alella
    Scientific Reports.2026;[Epub]     CrossRef
  • The use of a methylene blue and glyceryl trinitrate-based cream for the treatment of chronic anal fissures: a phase II randomized pilot trial from a referral coloproctological unit
    P. Lobascio, G. Tomasicchio, N. Cassetta, D. F. Altomare, G. Gallo, A. Pezzolla, R. Laforgia
    Techniques in Coloproctology.2025;[Epub]     CrossRef
  • Belgian consensus guideline on the management of anal fissures
    P Roelandt, G Bislenghi, G Coremans, D De Looze, M.A. Denis, H De Schepper, P Dewint, J Geldof, I Gijsen, N Komen, H Ruymbeke, J Stijns, M Surmont, D Van de Putte, S Van den Broeck, B Van Geluwe, J Wyndaele
    Acta Gastro Enterologica Belgica.2024; 87(2): 304.     CrossRef
  • Use of Botulinum Toxin Injections for the Treatment of Chronic Anal Fissure: Results From an American Society of Colon and Rectal Surgeons Survey
    Daniel J. Borsuk, Adam Studniarek, John J. Park, Slawomir J. Marecik, Anders Mellgren, Kunal Kochar
    The American Surgeon™.2023; 89(3): 346.     CrossRef
  • New Findings at the Internal Anal Sphincter on Cadaveric Dissection and Review of Sphincter-Related Surgery in a Newer Prospective
    Aswini Kumar Pujahari
    Indian Journal of Surgery.2023; 85(3): 585.     CrossRef
  • Pelvic floor physical therapy in patients with chronic anal fissure: long-term follow-up of a randomized controlled trial
    Daniëlle A. van Reijn-Baggen, Henk W. Elzevier, H. Putter, Rob C. M. Pelger, Ingrid J. M. Han-Geurts
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Fissurectomy with mucosal advancement flap anoplasty: The end of a dogma?
    M. Skoufou, J.H. Lefèvre, A. Fels, N. Fathallah, P. Benfredj, V. de Parades
    Journal of Visceral Surgery.2023; 160(5): 330.     CrossRef
  • Fissurectomy versus lateral internal sphincterotomy in the treatment of chronic anal fissures: no advantages in terms of post-operative incontinence
    Roberta Tutino, Casimiro Nigro, Flavia Paternostro, Rosa Federico, Giacomo Lo Secco, Gaetano Gallo, Mauro Santarelli, Gianfranco Cocorullo, Sebastiano Bonventre
    Techniques in Coloproctology.2023; 27(10): 885.     CrossRef
  • The Italian Unitary Society of Colon-proctology (SIUCP: Società Italiana Unitaria di Colonproctologia) guidelines for the management of anal fissure
    Antonio Brillantino, Adolfo Renzi, Pasquale Talento, Francesca Iacobellis, Luigi Brusciano, Luigi Monaco, Domenico Izzo, Alfredo Giordano, Michele Pinto, Corrado Fantini, Marcello Gasparrini, Michele Schiano Di Visconte, Francesca Milazzo, Giovanni Ferrer
    BMC Surgery.2023;[Epub]     CrossRef
  • La fissurectomie avec anoplastie muqueuse : la fin d’un dogme ?
    Maria Skoufou, Jérémie H. Lefèvre, Audrey Fels, Nadia Fathallah, Paul Benfredj, Vincent de Parades
    Journal de Chirurgie Viscérale.2023; 160(5): 363.     CrossRef
  • Modified open posterior internal sphincterotomy with sliding skin graft for chronic anal fissure and anal stenosis: Low recurrence rate and no serious faecal incontinence postoperative complication
    Y. Iida, K. Honda, R. Iida, H. Saitou, Y. Munemoto, A. Tanaka, H. Tanaka
    Journal of Visceral Surgery.2022; 159(4): 267.     CrossRef
  • Sphinctérotomie interne postérieure modifiée avec un lambeau cutané pour fissure anale et sténose anale : peu de récidives et d’incontinence anale
    Y. Iida, K. Honda, R. Iida, H. Saitou, Y. Munemoto, A. Tanaka, H. Tanaka
    Journal de Chirurgie Viscérale.2022; 159(4): 283.     CrossRef
  • Injection of botulinum toxin significantly increases efficiency of fissurectomy in the treatment of chronic anal fissures
    Philip Roelandt, Georges Coremans, Jan Wyndaele
    International Journal of Colorectal Disease.2022; 37(2): 309.     CrossRef
  • Clinical Trial Combining Botulinum Toxin A Injection and Fissurectomy for Chronic Anal Fissure: A Dose-Dependent Study
    Nuha Alsaleh, Abdullah I. Aljunaydil, Gaida A. Aljamili
    Journal of Coloproctology.2022; 42(02): 167.     CrossRef
  • Fisurectomy and anoplasty with botulinum toxin injection in patients with chronic anal posterior fissure with hypertonia: a long-term evaluation
    Beatrice D’Orazio, Girolamo Geraci, Guido Martorana, Carmelo Sciumé, Giovanni Corbo, Gaetano Di Vita
    Updates in Surgery.2021; 73(4): 1575.     CrossRef
  • The comparison between the medical and the surgical management of chronic anal fissures
    Navneet Mishra, Kamal Kishore Parmar, Tanweerul Huda
    Journal of Clinical and Investigative Surgery.2021; 6(1): 11.     CrossRef
  • Anocutaneous advancement flap provides a quicker cure than fissurectomy in surgical treatment for chronic anal fissure—a retrospective, observational study
    Edgar Hancke, Katrin Suchan, Knut Voelke
    Langenbeck's Archives of Surgery.2021; 406(8): 2861.     CrossRef
  • Fissurectomy Versus Lateral Internal Sphincterotomy in the Treatment of Chronic Anal Fissure: A Randomized Control Trial
    Bipin Kishore Bara, Sujit Kumar Mohanty, Satya Narayan Behera, Ashok Kumar Sahoo, Santanu Kumar Swain
    Cureus.2021;[Epub]     CrossRef
  • Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
    Beatrice D'Orazio, Girolamo Geraci, Fausto Famà, Gloria Terranova, Gaetano Di Vita
    World Journal of Clinical Cases.2021; 9(32): 9722.     CrossRef
  • Scanner-Assisted CO2 Laser Fissurectomy: A Pilot Study
    Iacopo Giani, Tommaso Cioppa, Chiara Linari, Filippo Caminati, Paolo Dreoni, Gianni Rossi, Cinzia Tanda, Giuseppina Talamo, Federico Bettazzi, Alessandra Aprile, Silvia Grassi, Antonella Pede, Luca Giannoni, Claudio Elbetti
    Frontiers in Surgery.2021;[Epub]     CrossRef
  • Fissurectomy combined with botulinum toxin A: a review of short- and long-term efficacy of this treatment strategy for chronic anal fissure; a consecutive proposal of a treatment algorithm for chronic anal fissure
    M. Trzpis, J. M. Klaase, R. H. Koop, P. M. A. Broens
    coloproctology.2020; 42(5): 400.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP